4
Changes in Ownership
Corvus Pharmaceuticals, Inc. Filed Acc 0001209191-16-111003
10% owner bought 666,666 shares at $15.00 ($9,999,990)
- 10% owner acquired 2,487,380 shares (conversion)
From the SEC's structured data for this filing
Trades in this filing
Novo A/S · 10% owner
Table I: Non-derivative
3 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2016-03-29 | Conversion : show line 1 in the form | +2,130,492 | 2,130,492 | D | ||
| 2016-03-29 | Conversion : show line 2 in the form | +356,888 | 2,487,380 | D | ||
| 2016-03-29 | Purchase : show line 3 in the form | +666,666 | $15.00 | $9,999,990 | 3,154,046 | D |
| Open-market purchases · 666,666 sh · avg $15.00 · $9,999,990 | ||||||
Table II: Derivative
2 lines| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2016-03-29 | Conversion : show line 4 in the form Series A Preferred Stock | −2,130,492 | 0 | D |
| 2016-03-29 | Conversion : show line 5 in the form Series B Preferred Stock | −356,888 | 0 | D |
Loading xslF345X03/doc4.xml…